CBS 2019
CBSMD教育中心
中 文

Congestive Heart Failure

Abstract

Recommended Article

Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction Myeloid-Derived Growth Factor Protects Against Pressure Overload–Induced Heart Failure by Preserving Sarco/Endoplasmic Reticulum Ca2+-ATPase Expression in Cardiomyocytes Seattle Heart Failure and Proportional Risk Models Predict Benefit From Implantable Cardioverter-Defibrillators The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems The Evolution of β-Blockers in Coronary Artery Disease and Heart Failure (Part 1/5)

Review Article2006 Jun 20;113(24):2851-60.

JOURNAL:Circulation. Article Link

Stage B heart failure: management of asymptomatic left ventricular systolic dysfunction

Goldberg LR, Jessup M. Keywords: Stage B Heart Failure; LVEF; left ventricular systolic dysfunction;

FULL TEXT PDF